ResMed(RMD) - 2025 Q4 - Earnings Call Transcript

ResMed (RMD) Q4 2025 Earnings Call July 31, 2025 04:30 PM ET Company ParticipantsSalli Schwartz - Chief Investor Relations OfficerMichael Farrell - CEO & ChairmanBrett Sandercock - CFOCraig Wong-Pan - Director - Equity ResearchAnthony Petrone - MD - Equity ResearchMatt Taylor - Managing DirectorConference Call ParticipantsDan Hurren - Healthcare AnalystDavinthra Thillainathan - Healthcare Equity AnalystSaul Hadassin - Analyst - Healthcare ServicesDavid Bailey - Equity Research AnalystBrett Fishbin - VP - Se ...